![Stan Chamberlain](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Stan Chamberlain worked as a Vice President-Chemistry at Inhibitex LLC.
Prior to that, he was a Senior Group Manager at GlaxoSmithKline Research & Development from 2001 to 2007, and a Group Leader-Medicinal Chemistry at Glaxo Wellcome, Inc. from 1995 to 2001.
Chamberlain received his undergraduate and doctorate degrees from the University of Iowa.
Former positions of Stan Chamberlain
Companies | Position | End |
---|---|---|
GlaxoSmithKline Research & Development
![]() GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC | Corporate Officer/Principal | 2006-12-31 |
Glaxo Wellcome, Inc. | Corporate Officer/Principal | 2000-12-31 |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Corporate Officer/Principal | - |
Training of Stan Chamberlain
University of Iowa | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
GlaxoSmithKline Research & Development
![]() GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC | Health Technology |
- Stock Market
- Insiders
- Stan Chamberlain